Considerations for implementation of vancomycin Bayesian software monitoring in a level IV NICU population within a multisite health system.
Meredith B OliverKimberly D BoeserMelissa K CarlsonLizbeth HansenPublished in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (2023)
This article serves to share our experience with selecting, planning, and implementing Bayesian software for vancomycin AUC monitoring in a neonatal population. Other health systems and children's hospitals can utilize our experience to evaluate a variety of MIPD software and consider neonatal nuances prior to implementation.